Risk Assessment in Drug Development: Autoimmunity

ISSN： 1087-2620

Source： Journal of Toxicology and Environmental Health, Vol.69, Iss.9, 2006-05, pp. : 893-898

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Reduction in Drug Discovery and Development

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1087-1090

Bentham Science Publishers

Access to resources Recommend Favorite

The Practice of Pre-Marketing Safety Assessment in Drug Development

By Chuang-Stein Christy Xia H. Amy

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 3-25

Taylor & Francis Ltd

Access to resources Recommend Favorite

Paediatric Assessment: An Essential Part of Standard Drug Development

By Milne Christopher-Paul

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 5, 2006-01 ,pp. : 297-301

Adis International

Access to resources Recommend Favorite

The Assessment of Platelet Activation in Antiplatelet Drug Development

Current Medicinal Chemistry, Vol. 12, Iss. 26, 2005-12 ,pp. : 3117-3125

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Eluting Stents in Percutaneous Coronary Intervention: A Benefit-Risk Assessment

By Byrne Robert A. Sarafoff Nikolaus Kastrati Adnan Schömig Albert

Drug Safety, Vol. 32, Iss. 9, 2009-09 ,pp. : 749-770

Adis International

Access to resources Recommend Favorite